Show simple item record

dc.contributor.authorLu, Lenette L.
dc.contributor.authorSmith, Malisa T.
dc.contributor.authorYu, Krystle K. Q.
dc.contributor.authorLuedemann, Corinne
dc.contributor.authorSuscovich, Todd J.
dc.contributor.authorGrace, Patricia S.
dc.contributor.authorCain, Adam
dc.contributor.authorYu, Wen-Han
dc.contributor.authorMcKitrick, Tanya R.
dc.contributor.authorLauffenburger, Douglas A
dc.contributor.authorCummings, Richard D.
dc.contributor.authorMayanja-Kizza, Harriet
dc.contributor.authorHawn, Thomas R.
dc.contributor.authorBoom, W. Henry
dc.contributor.authorStein, Catherine M.
dc.contributor.authorFortune, Sarah M.
dc.contributor.authorSeshadri, Chetan
dc.contributor.authorAlter, Galit
dc.date.accessioned2020-06-25T14:49:00Z
dc.date.available2020-06-25T14:49:00Z
dc.date.issued2019-05
dc.date.submitted2018-11
dc.identifier.issn1078-8956
dc.identifier.issn1546-170X
dc.identifier.urihttps://hdl.handle.net/1721.1/125979
dc.description.abstractExposure to Mycobacterium tuberculosis (Mtb) results in heterogeneous clinical outcomes including primary progressive tuberculosis and latent Mtb infection (LTBI). Mtb infection is identified using the tuberculin skin test and interferon-γ (IFN-γ) release assay IGRA, and a positive result may prompt chemoprophylaxis to prevent progression to tuberculosis. In the present study, we report on a cohort of Ugandan individuals who were household contacts of patients with TB. These individuals were highly exposed to Mtb but tested negative disease by IFN-γ release assay and tuberculin skin test, ‘resisting’ development of classic LTBI. We show that ‘resisters’ possess IgM, class-switched IgG antibody responses and non-IFN-γ T cell responses to the Mtb-specific proteins ESAT6 and CFP10, immunologic evidence of exposure to Mtb. Compared to subjects with classic LTBI, ‘resisters’ display enhanced antibody avidity and distinct Mtb-specific IgG Fc profiles. These data reveal a distinctive adaptive immune profile among Mtb-exposed subjects, supporting an expanded definition of the host response to Mtb exposure, with implications for public health and the design of clinical trials.en_US
dc.description.sponsorshipBill and Melinda Gates Foundation (Grant OPP1109001)en_US
dc.description.sponsorshipBill and Melinda Gates Foundation (Grant OPP1151840)en_US
dc.description.sponsorshipBill and Melinda Gates Foundation (Grant OPP1156795)en_US
dc.language.isoen
dc.publisherSpringer Science and Business Media LLCen_US
dc.relation.isversionofhttp://dx.doi.org/10.1038/s41591-019-0441-3en_US
dc.rightsCreative Commons Attribution 4.0 International licenseen_US
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/en_US
dc.sourceNatureen_US
dc.titleIFN-γ-independent immune markers of Mycobacterium tuberculosis exposureen_US
dc.typeArticleen_US
dc.identifier.citationLu, Lenette L. et al. "IFN-γ-independent immune markers of Mycobacterium tuberculosis exposure." Nature Medicine 25, 6 (May 2019): 977–987 © 2019 The Author(s)en_US
dc.contributor.departmentMassachusetts Institute of Technology. Department of Biological Engineeringen_US
dc.relation.journalNature Medicineen_US
dc.eprint.versionFinal published versionen_US
dc.type.urihttp://purl.org/eprint/type/JournalArticleen_US
eprint.statushttp://purl.org/eprint/status/PeerRevieweden_US
dc.date.updated2020-03-12T14:27:37Z
dspace.date.submission2020-03-12T14:27:42Z
mit.journal.volume25en_US
mit.journal.issue6en_US
mit.licensePUBLISHER_CC
mit.metadata.statusComplete


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record